Investor Relations-Information Disclosure

Technical Innovation Operational Excellence

Investor Presentation

31 May 2026

Henlius Post-2026 ASCO Business Update
22 March 2026

Henlius 2025 Annual Results
15 January 2026

The 44th J.P. Morgan Healthcare Conference
2 November 2025

HLX43 Data Readout
2 November 2025

INTERNATIONAL SUMMIT ON FRONTIERS AND INNOVATIONS IN LUNG CANCER
10 September 2025

Henlius Post-2025 WCLC Business Update
25 August 2025

Henlius 1H25 Results Investor Presentation
3 June 2025

Henlius Post-2025 ASCO Business Update
18 April 2025

Henlius 2025 Global R&D Day
24 March 2025

Henlius 2024 Annual Results
26 August 2024

Henlius 1H24 Results Investor Presentation
21 March 2024

Henlius 2023 Annual Results
15 November 2023

Henlius 3Q23 Results Investor Presentation
25 August 2023

Henlius 1H23 Results Investor Presentation
31 March 2023

Henlius 2022 Annual Results
18 August 2022

Henlius 1H22 Results Investor Presentation
16 March 2022

Henlius 2021 Annual Results
18 August 2021

Henlius 1H21 Results Investor Presentation
26 March 2021

Henlius 2020 Annual Results
30 September 2020

Henlius Recent Business Update
24 August 2020

Henlius 1H20 Results Investor Presentation
13 June 2020

Henlius Global R&D Day
24 April 2020

Henlius HLX02(trastuzumab) EU GMP approval